Optical imaging of metastatic tumors using a folate-targeted fluorescent probe

Journal of Biomedical Optics

Volumn 8, Issue 4, 2003, Pages 636-641

  Kennedy, Michael D ^a   Jallad, Karim N ^a   Thompson, David H ^a   Ben Amotz, Dor ^a   Low, Philip S ^a  

^a PURDUE UNIVERSITY   (United States)

Author keywords

Folate receptor; Folate fluorescent probe conjugates; Optical imaging of tumors; Tumor targeting

Indexed keywords

METASTATIC LESIONS; PHOTOBLEACHING;

CELLS; COMPUTER SOFTWARE; FLUORESCENCE; IMAGE RECONSTRUCTION; LASER APPLICATIONS; MEDICAL IMAGING; SPECTROGRAPHS; VITAMINS;

TUMORS;

CARRIER PROTEIN; CELL SURFACE RECEPTOR; DIAGNOSTIC AGENT; FLUORESCENT DYE; FOLATE BINDING PROTEIN; FOLATE-BINDING PROTEIN; FOLIC ACID; TUMOR MARKER;

ANIMAL; ARTICLE; BAGG ALBINO MOUSE; COMPARATIVE STUDY; EVALUATION; FLUORESCENCE MICROSCOPY; METABOLISM; METASTASIS; METHODOLOGY; MOUSE; NEOPLASM; PATHOLOGY; PERITONEUM TUMOR; SKIN TUMOR; TUMOR CELL LINE;

ANIMALS; CARRIER PROTEINS; CELL LINE, TUMOR; FLUORESCENT DYES; FOLIC ACID; MICE; MICE, INBRED BALB C; MICROSCOPY, FLUORESCENCE; NEOPLASM METASTASIS; NEOPLASMS; NEOPLASMS, UNKNOWN PRIMARY; PERITONEAL NEOPLASMS; RECEPTORS, CELL SURFACE; SKIN NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 0348223342     PISSN: 10833668     EISSN: None     Source Type: Journal    
DOI: 10.1117/1.1609453     Document Type: Article

References (49)

1. M. V. Knopp, E. Weiss, H. P. Sinn, J. Mattern, H. Junkermann, J. Radeleff, A. Magener, G. Brix, S. Delorme, I. Zuna, and G. van Kaick, "Pathophysiologic basis of contrast enhancement in breast tumors," J. Magn. Reson Imaging 10, 260-266 (1999).
2. P. J. Hudson, "Recombinant antibodies: a novel approach to cancer diagnosis and therapy," Expert Opin. Invest. Drugs 9, 1231-1242 (2000).
3. S. D. Jonson and M. J. Welch, "PET imaging of breast cancer with fluorine-18 radiolabeled estrogens and progestins," Q. J. Nucl. Med. 42, 8-17 (1998).
4. A. Heppeler, S. Froidevaux, A. N. Eberle, and H. R. Maecke, "Receptor targeting for tumor localisation and therapy with radiopeptides," Curr. Med. Chem. 1, 971-994 (2000).
5. J. C. Reubi, "The role of peptides and their receptors as tumor markers," Endocrinol Metab. Clin. North Am. 22, 917-939 (1993).
6. J. A. Reddy and P. S. Low, "Folate-mediated targeting of therapeutic and imaging agents to cancers," Crit. Rev. Ther. Drug Carrier Syst. 15, 587-627 (1998).
7. X. Wang, F. Shen, J. H. Freisheim, L. E. Gentry, and M. Ratnam, "Differential stereospecificities and affinities of folate receptor isoforms for folate compounds and antifolates," Biochem. Pharmacol. 44, 1898-1901 (1992).
8. T. A. Patrick, D. M. Kranz, T. A. van Dyke, and E. J. Roy, "Folate receptors as potential therapeutic targets in choroid plexus tumors of SV40 transgenic mice," J. Neuro-Oncol. 32, 111-123 (1997).
9. G. Toffoli, C. Cernigoi, A. Russo, A. Gallo, M. Bagnoli, and M. Boiocchi, "Overexpression of folate binding protein in ovarian cancers," Int. J. Cancer 74, 193-198 (1997).
10. P. Garin-Chesa, I. Campbell, P. E. Saigo, J. L. Lewis, Jr., L. J. Old, and W. J. Rettig, "Trophoblast and ovarian cancer antigen LK26. Sensitivity and specificity in immunopathology and molecular identification as a folate-binding protein," Am. J. Pathol 142, 557-567 (1993).
11. W. J. Rettig, C. Cordon-Cardo, J. P. Koulos, J. L. Lewis, H. F. Oettgen, and L. J. Old, "Cell surface antigens of human trophoblast and choriocarcinoma defined by monoclonal antibodies," Int. J. Cancer 35, 469-475 (1985).
12. W. A. Franklin, M. Waintrub, D. Edwards, K. Christensen, P. Prendegrast, J. Woods, P. A. Bunn, and J. F. Kolhouse, "New anti-lung-cancer antibody cluster 12 reacts with human folate receptors present on adenocarcinoma," Int. J. Cancer 8, 89-95 (1994).
13. J. F. Ross, H. Wang, F. G. Behm, P. Mathew, M. Wu, R. Booth, and M. Ratnam, "Folate receptor type beta is a neutrophilic lineage marker and is differentially expressed in myeloid leukemia," Cancer 85, 348-357 (1999).
14. S. D. Weitman, R. H. Lark, L. R. Coney, D. W. Fort, V. Frasca, V. R. Zurawski, Jr., and B. A. Kamen, "Distribution of the folate receptor GP38 in normal and malignant cell lines and tissues," Cancer Res. 52, 3396-4401 (1992).
15. S. D. Konda, M. Aref, M. Brechbiel, and E. C. Wiener, "Development of a tumor-targeting MR contrast agent using the high-affinity folate receptor: work in progress," Invest. Radiol. 35, 50-57 (2000).
16. S. Wang, J. Luo, D. A. Lantrip, D. J. Waters, C. J. Mathias, M. A. Green, P. L. Fuchs, and P. S. Low, "Design and synthesis of [111In]DTPA-folate for use as a tumor-targeted radiopharmaceutical," Bioconjugate Chem. 8, 673-679 (1997).
17. C. H. Tung, Y. Lin, W. K. Moon, and R. Weissleder, "A receptor-targeted near-infrared fluorescence probe for in vivo tumor imaging," Chembiochem. 8, 784-786 (2002).
18. N. P. Barry, A. Bower, S. D. Konda, A. Singha, E. C. Wiener, and E. C. Gratton, "Near infrared contrast agent for tumor cells expressing the high affinity folate receptor," Biophys. J. 80, 656.39 (2001).
19. D. E. Fleischer, "Chromoendoscopy and magnification endoscopy in the colon," Gastrointest Endosc 49, S45-S49 (1999).
20. H. Stepp, R. Sroka, and R. Baumgartner, "Fluorescence endoscopy of gastrointestinal diseases: basic principles, techniques, and clinical experience," Endoscopy 30, 379-386 (1998).
21. M. M. Acosta and H. W. Boyce, Jr., "Chromoendoscopy - where is it useful?" J. Clin. Gastroenterol. 27, 13-20 (1998).
22. M. D. Kennedy, K. Jallad, J. Lu, S. Low Philip, and D. Ben-Amotz, "Evaluation of folate conjugate uptake and transport by the choroid plexus of mice," Pharm. Res. 20, 714-719 (2003).
23. S. Wang, R. J. Lee, C. J. Mathias, M. A. Green, and P. S. Low, "Synthesis, purification, and tumor cell uptake of 67Ga-deferoxamine - folate, a potential radiopharmaceutical for tumor imaging," Bioconjugate Chem. 7, 56-62 (1996).
24. S. Achilefu, R. Dorshow, J. Bugaj, and R. Rajagopalan, "Novel receptor-targeted fluorescent contrast agents for in vivo tumor imaging," Invest. Radiol. 35, 479-485 (2000).
25. A. Becker, C. Hessenius, K. Licha, B. Ebert, U. Sukowski, W. Semmler, B. Wiedenmann, and C. Grotzinger, "Receptor-targeted optical imaging of tumors with near-infrared fluorescent ligands," Nat. Biotechnol. 19, 327-331 (2001).
26. C. J. Mathias, S. Wang, D. J. Waters, J. J. Turek, P. S. Low, and M. A. Green, "Indium-111-DTPA-folate as a potential folate-receptor-targeted radiopharmaceutical," J. Nucl. Med. 39, 1579-1585 (1998).
27. C. J. Mathias, S. Wang, P. S. Low, D. J. Waters, and M. A. Green, "Receptor-mediated targeting of 67Ga-deferoxamine-folate to folate-receptor-positive human KB tumor xenografts," Nucl. Med. Biol. 26, 23-25 (1999).
28. C. J. Mathias, D. Hubers, P. S. Low, and M. A. Green, "Synthesis of [(99m)Tc]DTPA-folate and its evaluation as a folate-receptor-targeted radiopharmaceutical," Bioconjugate Chem. 11, 253-257 (2000).
29. M. Ratnam and J. H. Freisheim, Folic Acid Metabolism in Health and Disease, pp. 91-120, Wiley Liss, New York (1990).
30. T. P. McAlinden, J. B. Hynes, S. A. Patil, G. R. Westerhof, G. Jansen, J. H. Schornagel, S. S. Kerwar, and J. H. Freisheim, "Synthesis and biological evaluation of a fluorescent analogue of folic acid," Biochemistry 30, 5674-5681 (1991).
31. G. R. Gapski, J. M. Whiteley, J. I. Rader, P. L. Cramer, G. B. Henderson, V. Neef, and F. M. Huennekens, "Synthesis of a fluorescent derivative of amethopterin," J. Med. Chem. 18, 526-528 (1975).
32. G. B. Henderson, A. Russell, and J. M. Whiteley, "A fluorescent derivative of methotrexate as an intracellular marker for dihydrofolate reductase in L1210 cells," Arch. Biochem. Biophys. 202, 29-34 (1980).
33. I. G. Campbell, T. A. Jones, W. D. Foulkes, and J. Trowsdale, "Folate-binding protein is a marker for ovarian cancer," Cancer Res. 51, 5329-5338 (1991).
34. J. F. Ross, P. K. Chaudhuri, and M. Ratnam, "Differential regulation of folate receptor isoforms in normal and malignant tissues in vivo and in established cell lines. Physiologic and clinical implications," Cancer 73, 2432-2443 (1994).
35. M. Boente, A. Godwin, and W. Hogan, "Screening, imaging and early diagnosis of ovarian cancer," Clin. Obstet. Gynecol. 37, 377-391 (1994).
36. A. R. Munkarah, A. V. Hallum, M. Morris, T. W. Burke, C. Levenback, E. N. Atkinson, J. T. Wharton, and D. M. Gershenson, "Prognostic significance of residual disease in patients with stage IV epithelial ovarian cancer," Gynecol. Oncol. 64, 13-17 (1997).
37. J. P. Curtin, R. Malik, E. S. Venkatraman, R. R. Barakat, and W. J. Hoskins, "Stage IV ovarian cancer: impact of surgical debulking," Gynecol. Oncol. 64, 9-12 (1997).
38. L. Song, E. J. Hennink, I. T. Young, and H. J. Tanke, "Photobleaching kinetics of fluorescein in quantitative fluorescence microscopy," Biophys. J. 68, 2588-2600 (1995).
39. C. Murolo, S. Costantini, G. Foglia, T. Guido, F. Odicino, M. Pace, S. Parodi, G. Pino, N. Ragni, and L. Repetto, "Ultrasound examination in ovarian cancer patients. A comparison with second look laparotomy," J. Ultrasound Med. 8, 441-443 (1989).
40. M. Piver, S. Lele, J. Barlow et al., "Second-look laparoscopy prior to proposed second-look parotomy," Obstet. Gynecol. (N.Y., NY, U. S.) 55, 571 (1980).
41. B. Ballou, G. W. Fisher, A. S. Waggoner, D. L. Farkas, J. M. Reiland, R. Jaffe, R. B. Mujumdar, S. R. Mujumdar, and T. R. Hakala, "Tumor labeling in vivo using cyanine-conjugated monoclonal antibodies," Cancer Immunol. Immunother 41, 257-263 (1995).
42. B. Ballou, G. W. Fisher, T. R. Hakala, and D. L. Farkas, "Tumor detection and visualization using cyanine fluorochrome-labeled antibodies, " Biotechnol. Prog. 13, 649-658 (1997).
43. K. Licha, C. Hessenius, A. Becker, P. Henklein, M. Bauer, S. Wisniewski, B. Wiedenmann, and W. Semmler, "Synthesis, characterization, and biological properties of cyanine-labeled somatostatin analogues as receptor-targeted fluorescent probes," Bioconjugate Chem. 12, 44-50 (2001).
44. S. Folli, G. Wagnieres, A. Pelegrin, J. M. Calmes, D. Braichotte, F. Buchegger, Y. Chalandon, N. Hardman, C. Heusser, and J. C. Givel, "Immunophotodiagnosis of colon carcinomas in patients injected with fluoresceinated chimeric antibodies against carcinoembryonic antigen," Proc. Natl. Acad. Sci. U.S.A. 89, 7973-7977 (1992).
45. S. Folli, P. Westermann, D. Braichotte, A. Pelegrin, G. Wagnieres, H. van den Bergh, and J. P. Mach, "Antibody-indocyanin conjugates for immunophotodetection of human squamous cell carcinoma in nude mice," Cancer Res. 54, 2643-2649 (1994).
46. R. Hornung, A. L. Major, M. McHale, L. H. L. Liaw, L. A. Sabiniano, B. J. Tromberg, M. W. Berns, and Y. Tadir, "In vivo detection of metastatic ovarian cancer by means of 5-aminolevulinic acid-induced fluorescence in a rat model," J. Am. Assoc. Gynecol. Laparosc 5, 141-148 (1998).
47. M. M. Haglund, M. S. Berger, and D. W. Hochman, "Enhanced optical imaging of human gliomas and tumor margins," Neurosurgery 38, 308-317 (1996).
48. B. Ballou, G. W. Fisher, J. S. Deng, T. R. Hakala, M. Srivastava, and D. L. Farkas, "Cyanine fluorochrome-labeled antibodies in vivo: assessment of tumor imaging using Cy3, Cy5, Cy5.5, and Cy7," Cancer Detect. Prev. 22, 251-257 (1998).
49. C. H. Tung, S. Bredow, U. Mahmood, and R. Weissleder, "Preparation of a cathepsin D sensitive near-infrared fluorescence probe for imaging," Bioconjugate Chem. 10, 892-896 (1999).